NPAS2 and cancer: Intriguingly, given that cancer prognosis and survival have been associated with the level of circadian disruption in patient tumor tissues [30], clock genes, such as Bmal1, Per1 and npas2, could be considered potential prognostic biomarkers in certain cancers [31,32].